Thyroid remnant ablation in differentiated thyroid carcinoma: when and how

Clinical and Translational Imaging - Tập 1 Số 3 - Trang 195-203 - 2013
Verburg, Frederik A.1,2, Hänscheid, Heribert3, Luster, Markus4
1Department of Nuclear Medicine, Aachen University Hospital, Aachen, Germany
2Department of Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
3Department of Nuclear Medicine, Würzburg University Hospital, Würzburg, Germany
4Department of Nuclear Medicine, Ulm University Hospital, Ulm, Germany

Tóm tắt

131I ablation is considered an effective and safe adjuvant therapy modality for differentiated thyroid cancer (DTC), although there is an ongoing debate about the need for 131I ablation in patients without lymph node or distant metastases and with low stages of the primary (pT1-2) tumor. However, on the basis of evidence from retrospective studies and pending the results of ongoing controlled prospective randomized trials, it seems advisable to perform 131I remnant ablation in patients with primary tumors >1 cm. For thyroid remnant ablation, individual dosimetry is not generally considered necessary, but it may improve success rates if used according to strict criteria. The use of recombinant human TSH (rhTSH) for patient preparation allows maintenance of quality of life and results in a lower radiation exposure of healthy non-thyroid tissue compared with TSH stimulation through levothyroxine withdrawal. This approach has been approved for 131I ablation, but not for 131I therapy of distant metastases.

Tài liệu tham khảo

citation_journal_title=Thyroid; citation_title=Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer; citation_author=DS Cooper, GM Doherty, BR Haugen, RT Kloos, SL Lee, SJ Mandel, EL Mazzaferri, B McIver, F Pacini, M Schlumberger, SI Sherman, DL Steward, RM Tuttle; citation_volume=19; citation_publication_date=2009; citation_pages=1167-1214; citation_doi=10.1089/thy.2009.0110; citation_id=CR1 citation_journal_title=Eur J Endocrinol; citation_title=European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium; citation_author=F Pacini, M Schlumberger, H Dralle, R Elisei, JW Smit, W Wiersinga; citation_volume=154; citation_publication_date=2006; citation_pages=787-803; citation_doi=10.1530/eje.1.02158; citation_id=CR2 citation_journal_title=Ann Oncol; citation_title=Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up; citation_author=F Pacini, MG Castagna, L Brilli, G Pentheroudakis; citation_volume=21; citation_issue=Suppl 5; citation_publication_date=2010; citation_pages=v214-v219; citation_doi=10.1093/annonc/mdq190; citation_id=CR3 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Guidelines for radioiodine therapy of differentiated thyroid cancer; citation_author=M Luster, SE Clarke, M Dietlein, M Lassmann, P Lind, WJ Oyen, J Tennvall, E Bombardieri; citation_volume=35; citation_publication_date=2008; citation_pages=1941-1959; citation_doi=10.1007/s00259-008-0883-1; citation_id=CR4 citation_journal_title=Clin Endocrinol (Oxf); citation_title=Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma; citation_author=S Diessl, B Holzberger, U Mader, I Grelle, JW Smit, AK Buck, C Reiners, FA Verburg; citation_volume=76; citation_publication_date=2012; citation_pages=586-592; citation_doi=10.1111/j.1365-2265.2011.04272.x; citation_id=CR5 citation_journal_title=Endocr Pract; citation_title=American association of clinical endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules; citation_author=; citation_volume=12; citation_publication_date=2006; citation_pages=63-102; citation_id=CR6 citation_journal_title=Langenbecks Arch Surg; citation_title=German association of endocrine surgeons practice guidelines for the surgical treatment of benign thyroid disease; citation_author=TJ Musholt, T Clerici, H Dralle, A Frilling, PE Goretzki, MM Hermann, J Kussmann, K Lorenz, C Nies, J Schabram, P Schabram, C Scheuba, D Simon, T Steinmuller, AW Trupka, RA Wahl, A Zielke, A Bockisch, W Karges, M Luster, KW Schmid; citation_volume=396; citation_publication_date=2011; citation_pages=639-649; citation_doi=10.1007/s00423-011-0774-y; citation_id=CR7 citation_journal_title=Am J Med; citation_title=Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer; citation_author=EL Mazzaferri, SM Jhiang; citation_volume=97; citation_publication_date=1994; citation_pages=418-428; citation_doi=10.1016/0002-9343(94)90321-2; citation_id=CR8 citation_journal_title=Nat Rev Endocrinol; citation_title=Radioiodine for remnant ablation and therapy of metastatic disease; citation_author=C Reiners, H Hanscheid, M Luster, M Lassmann, FA Verburg; citation_volume=7; citation_publication_date=2011; citation_pages=589-595; citation_doi=10.1038/nrendo.2011.134; citation_id=CR9 citation_journal_title=J Clin Endocrinol Metab; citation_title=Life expectancy is reduced in differentiated thyroid cancer patients ≥45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients; citation_author=FA Verburg, U Mader, K Tanase, ED Thies, S Diessl, AK Buck, M Luster, C Reiners; citation_volume=98; citation_publication_date=2013; citation_pages=172-180; citation_doi=10.1210/jc.2012-2458; citation_id=CR10 citation_journal_title=Eur J Endocrinol; citation_title=Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients; citation_author=FA Verburg, B Keizer, CJ Lips, PM Zelissen, JM Klerk; citation_volume=152; citation_publication_date=2005; citation_pages=33-37; citation_doi=10.1530/eje.1.01819; citation_id=CR11 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer; citation_author=FA Verburg, MP Stokkel, C Duren, RB Verkooijen, U Mader, JW Isselt, RJ Marlowe, JW Smit, C Reiners, M Luster; citation_volume=37; citation_publication_date=2010; citation_pages=276-283; citation_doi=10.1007/s00259-009-1315-6; citation_id=CR12 citation_journal_title=J Biol Chem; citation_title=Thyroid Na +/I- symporter. Mechanism, stoichiometry, and specificity; citation_author=S Eskandari, DD Loo, G Dai, O Levy, EM Wright, N Carrasco; citation_volume=272; citation_publication_date=1997; citation_pages=27230-27238; citation_doi=10.1074/jbc.272.43.27230; citation_id=CR13 citation_journal_title=N Engl J Med; citation_title=Papillary and follicular thyroid carcinoma; citation_author=MJ Schlumberger; citation_volume=338; citation_publication_date=1998; citation_pages=297-306; citation_doi=10.1056/NEJM199801293380506; citation_id=CR14 citation_journal_title=J Clin Endocrinol Metab; citation_title=Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer; citation_author=EL Mazzaferri, RT Kloos; citation_volume=86; citation_publication_date=2001; citation_pages=1447-1463; citation_doi=10.1210/jc.86.4.1447; citation_id=CR15 citation_journal_title=Cancer; citation_title=Long-term results and prognostic factors in patients with differentiated thyroid carcinoma; citation_author=M Tubiana, M Schlumberger, P Rougier, A Laplanche, E Benhamou, P Gardet, B Caillou, JP Travagli, C Parmentier; citation_volume=55; citation_publication_date=1985; citation_pages=794-804; citation_doi=10.1002/1097-0142(19850215)55:4<794::AID-CNCR2820550418>3.0.CO;2-Z; citation_id=CR16 citation_journal_title=Int J Radiat Oncol Biol Phys; citation_title=Papillary and follicular thyroid cancer: impact of treatment in 1578 patients; citation_author=WJ Simpson, T Panzarella, JS Carruthers, MK Gospodarowicz, SB Sutcliffe; citation_volume=14; citation_publication_date=1988; citation_pages=1063-1075; citation_doi=10.1016/0360-3016(88)90381-1; citation_id=CR17 citation_journal_title=N Engl J Med; citation_title=Follow-up of patients with thyroid carcinoma; citation_author=RD Utiger; citation_volume=337; citation_publication_date=1997; citation_pages=928-930; citation_doi=10.1056/NEJM199709253371311; citation_id=CR18 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma; citation_author=FA Verburg, M Dietlein, M Lassmann, M Luster, C Reiners; citation_volume=36; citation_publication_date=2009; citation_pages=343-346; citation_doi=10.1007/s00259-008-0997-5; citation_id=CR19 citation_journal_title=N Engl J Med; citation_title=Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma; citation_author=TM Shattuck, WH Westra, PW Ladenson, A Arnold; citation_volume=352; citation_publication_date=2005; citation_pages=2406-2412; citation_doi=10.1056/NEJMoa044190; citation_id=CR20 citation_journal_title=J Clin Endocrinol Metab; citation_title=Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma; citation_author=SI Sherman, ET Tielens, S Sostre, MD Wharam, PW Ladenson; citation_volume=78; citation_publication_date=1994; citation_pages=629-634; citation_doi=10.1210/jc.78.3.629; citation_id=CR21 citation_journal_title=Eur J Cancer; citation_title=Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease; citation_author=F Tenenbaum, C Corone, M Schlumberger, C Parmentier; citation_volume=32A; citation_publication_date=1996; citation_pages=1262; citation_doi=10.1016/0959-8049(96)00020-2; citation_id=CR22 citation_journal_title=J Clin Endocrinol Metab; citation_title=Combination of radioiodine 131I and probe-guided surgery for persistent or recurrent thyroid carcinoma; citation_author=JP Travagli, AF Cailleux, M Ricard, E Baudin, B Caillou, C Parmentier, M Schlumberger; citation_volume=83; citation_publication_date=1998; citation_pages=2675-2680; citation_doi=10.1210/jc.83.8.2675; citation_id=CR23 citation_journal_title=Ann Intern Med; citation_title=Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma; citation_author=T Taylor, B Specker, J Robbins, M Sperling, M Ho, K Ain, ST Bigos, J Brierley, D Cooper, B Haugen, I Hay, V Hertzberg, I Klein, H Klein, P Ladenson, R Nishiyama, D Ross, S Sherman, HR Maxon; citation_volume=129; citation_publication_date=1998; citation_pages=622-627; citation_doi=10.7326/0003-4819-129-8-199810150-00007; citation_id=CR24 citation_journal_title=World J Surg; citation_title=Papillary thyroid carcinoma managed at the Mayo clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients; citation_author=ID Hay, GB Thompson, CS Grant, EJ Bergstralh, CE Dvorak, CA Gorman, MS Maurer, B McIver, BP Mullan, AL Oberg, CC Powell, JA Heerden, JR Goellner; citation_volume=26; citation_publication_date=2002; citation_pages=879-885; citation_doi=10.1007/s00268-002-6612-1; citation_id=CR25 citation_journal_title=J Clin Endocrinol Metab; citation_title=Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer; citation_author=AM Sawka, K Thephamongkhol, M Brouwers, L Thabane, G Browman, HC Gerstein; citation_volume=89; citation_publication_date=2004; citation_pages=3668-3676; citation_doi=10.1210/jc.2003-031167; citation_id=CR26 citation_journal_title=Eur J Endocrinol; citation_title=Post-surgical use of radioiodine 131I in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report; citation_author=F Pacini, M Schlumberger, C Harmer, GG Berg, O Cohen, L Duntas, F Jamar, B Jarzab, E Limbert, P Lind, C Reiners, FF Sanchez, J Smit, W Wiersinga; citation_volume=153; citation_publication_date=2005; citation_pages=651-659; citation_doi=10.1530/eje.1.02014; citation_id=CR27 citation_journal_title=Thyroid; citation_title=Is adjuvant therapy useful in patients with papillary carcinoma smaller than 2 cm?; citation_author=PW Rosario, MA Borges, MM Valadao, FP Vasconcelos, LL Rezende, EL Padrao, AL Barroso, S Purisch; citation_volume=17; citation_publication_date=2007; citation_pages=1225-1228; citation_doi=10.1089/thy.2006.0254; citation_id=CR28 citation_journal_title=Endocrinol Metab Clin North Am; citation_title=An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer; citation_author=AM Sawka, JD Brierley, RW Tsang, L Thabane, L Rotstein, A Gafni, S Straus, DP Goldstein; citation_volume=37; citation_publication_date=2008; citation_pages=457-480; citation_doi=10.1016/j.ecl.2008.02.007; citation_id=CR29 citation_journal_title=Thyroid; citation_title=Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis; citation_author=AM Sawka, L Thabane, L Parlea, I Ibrahim-Zada, RW Tsang, JD Brierley, S Straus, S Ezzat, DP Goldstein; citation_volume=19; citation_publication_date=2009; citation_pages=451-457; citation_doi=10.1089/thy.2008.0392; citation_id=CR30 citation_journal_title=Thyroid; citation_title=Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis; citation_author=S Subramanian, DP Goldstein, L Parlea, L Thabane, S Ezzat, I Ibrahim-Zada, S Straus, JD Brierley, RW Tsang, A Gafni, L Rotstein, AM Sawka; citation_volume=17; citation_publication_date=2007; citation_pages=1277-1288; citation_doi=10.1089/thy.2007.0171; citation_id=CR31 citation_journal_title=Cancer; citation_title=The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer; citation_author=MR Haymart, M Banerjee, D Yang, AK Stewart, RJ Koenig, JJ Griggs; citation_volume=119; citation_publication_date=2013; citation_pages=259-265; citation_doi=10.1002/cncr.27721; citation_id=CR32 citation_journal_title=J Clin Endocrinol Metab; citation_title=Morbidity and mortality in follicular thyroid cancer; citation_author=LJ DeGroot, EL Kaplan, MS Shukla, G Salti, FH Straus; citation_volume=80; citation_publication_date=1995; citation_pages=2946-2953; citation_doi=10.1210/jc.80.10.2946; citation_id=CR33 citation_journal_title=J Clin Endocrinol Metab; citation_title=The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients; citation_author=NA Samaan, PN Schultz, RC Hickey, H Goepfert, TP Haynie, DA Johnston, NG Ordonez; citation_volume=75; citation_publication_date=1992; citation_pages=714-720; citation_doi=10.1210/jc.75.3.714; citation_id=CR34 citation_journal_title=JAMA; citation_title=Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid; citation_author=SM Seidlin, LD Marinelli, E Oshry; citation_volume=132; citation_publication_date=1946; citation_pages=838-847; citation_doi=10.1001/jama.1946.02870490016004; citation_id=CR35 citation_journal_title=Clin Endocrinol (Oxf); citation_title=Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer; citation_author=SA Doi, NJ Woodhouse; citation_volume=52; citation_publication_date=2000; citation_pages=765-773; citation_doi=10.1046/j.1365-2265.2000.01014.x; citation_id=CR36 citation_journal_title=J Clin Endocrinol Metab; citation_title= 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review; citation_author=A Hackshaw, C Harmer, U Mallick, M Haq, JA Franklyn; citation_volume=92; citation_publication_date=2007; citation_pages=28-38; citation_doi=10.1210/jc.2006-1345; citation_id=CR37 citation_journal_title=Clin Med Res; citation_title=Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited; citation_author=SA Doi, NJ Woodhouse, L Thalib, A Onitilo; citation_volume=5; citation_publication_date=2007; citation_pages=87-90; citation_doi=10.3121/cmr.2007.763; citation_id=CR38 citation_journal_title=J Clin Endocrinol Metab; citation_title=Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis; citation_author=W Cheng, C Ma, H Fu, J Li, S Chen, S Wu, H Wang; citation_volume=98; citation_publication_date=2013; citation_pages=1353-1360; citation_doi=10.1210/jc.2012-3682; citation_id=CR39 citation_journal_title=N Engl J Med; citation_title=Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer; citation_author=U Mallick, C Harmer, B Yap, J Wadsley, S Clarke, L Moss, A Nicol, PM Clark, K Farnell, R McCready, J Smellie, JA Franklyn, R John, CM Nutting, K Newbold, C Lemon, G Gerrard, A Abdel-Hamid, J Hardman, E Macias, T Roques, S Whitaker, R Vijayan, P Alvarez, S Beare, S Forsyth, L Kadalayil, A Hackshaw; citation_volume=366; citation_publication_date=2012; citation_pages=1674-1685; citation_doi=10.1056/NEJMoa1109589; citation_id=CR40 citation_journal_title=N Engl J Med; citation_title=Strategies of radioiodine ablation in patients with low-risk thyroid cancer; citation_author=M Schlumberger, B Catargi, I Borget, D Deandreis, S Zerdoud, B Bridji, S Bardet, L Leenhardt, D Bastie, C Schvartz, P Vera, O Morel, D Benisvy, C Bournaud, F Bonichon, C Dejax, ME Toubert, S Leboulleux, M Ricard, E Benhamou; citation_volume=366; citation_publication_date=2012; citation_pages=1663-1673; citation_doi=10.1056/NEJMoa1108586; citation_id=CR41 citation_journal_title=Thyroid; citation_title=In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 mU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin; citation_author=LA Valle, RL Gorodeski Baskin, K Porter, JA Sipos, R Khawaja, MD Ringel, RT Kloos; citation_volume=23; citation_publication_date=2013; citation_pages=185-193; citation_doi=10.1089/thy.2012.0327; citation_id=CR42 citation_journal_title=J Clin Endocrinol Metab; citation_title=Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study; citation_author=F Pacini, PW Ladenson, M Schlumberger, A Driedger, M Luster, RT Kloos, S Sherman, B Haugen, C Corone, E Molinaro, R Elisei, C Ceccarelli, A Pinchera, RL Wahl, S Leboulleux, M Ricard, J Yoo, NL Busaidy, E Delpassand, H Hanscheid, R Felbinger, M Lassmann, C Reiners; citation_volume=91; citation_publication_date=2006; citation_pages=926-932; citation_doi=10.1210/jc.2005-1651; citation_id=CR43 citation_journal_title=Nuklearmedizin; citation_title=Improved follow-up of patients with differentiated thyroid carcinoma. The quantitative detection limit of 131I uptake in diagnostic scans; citation_author=S Diessl, F Verburg, J Biko, B Schryen, C Reiners, A Buck, H Hanscheid; citation_volume=52; citation_publication_date=2013; citation_pages=81-87; citation_id=CR44 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level; citation_author=H Hanscheid, FA Verburg, J Biko, S Diessl, YE Demidchik, V Drozd, C Reiners; citation_volume=38; citation_publication_date=2011; citation_pages=1296-1302; citation_doi=10.1007/s00259-011-1788-y; citation_id=CR45 citation_journal_title=Clin Oncol (R Coll Radiol); citation_title=Iodine or Not (IoN) for low-risk differentiated thyroid cancer: the next UK national cancer research network randomised trial following HiLo; citation_author=U Mallick, C Harmer, A Hackshaw, L Moss; citation_volume=24; citation_publication_date=2012; citation_pages=159-161; citation_doi=10.1016/j.clon.2012.01.001; citation_id=CR46 citation_journal_title=J Nucl Med; citation_title=Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal; citation_author=H Hanscheid, M Lassmann, M Luster, SR Thomas, F Pacini, C Ceccarelli, PW Ladenson, RL Wahl, M Schlumberger, M Ricard, A Driedger, RT Kloos, SI Sherman, BR Haugen, V Carriere, C Corone, C Reiners; citation_volume=47; citation_publication_date=2006; citation_pages=654; citation_id=CR47 citation_journal_title=J Nucl Med; citation_title=Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer; citation_author=AM Samuel, B Rajashekharrao, DH Shah; citation_volume=39; citation_publication_date=1998; citation_pages=1531-1536; citation_id=CR48 citation_journal_title=Q J Nucl Med Mol Imaging; citation_title=Individualized dosimetry in the management of metastatic differentiated thyroid cancer; citation_author=C Chiesa, MR Castellani, C Vellani, E Orunesu, A Negri, R Azzeroni, F Botta, M Maccauro, G Aliberti, E Seregni, M Lassmann, E Bombardieri; citation_volume=53; citation_publication_date=2009; citation_pages=546-561; citation_id=CR49 citation_journal_title=AJR; citation_title=The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer; citation_author=RS Benua, NR Cicale, M Sonenberg, RW Rawson; citation_volume=1962; citation_publication_date=1962; citation_pages=171-182; citation_id=CR50 citation_journal_title=J Nucl Med; citation_title=Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach; citation_author=R Dorn, J Kopp, H Vogt, P Heidenreich, RG Carroll, SA Gulec; citation_volume=44; citation_publication_date=2003; citation_pages=451-456; citation_id=CR51 citation_journal_title=J Nucl Med; citation_title=Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer; citation_author=RM Tuttle, R Leboeuf, RJ Robbins, R Qualey, K Pentlow, SM Larson, CY Chan; citation_volume=47; citation_publication_date=2006; citation_pages=1587-1591; citation_id=CR52 citation_journal_title=Thyroid; citation_title=The relative frequency in which empiric dosages of radioiodine would potentially overtreat or under treat patients who have metastatic well-differentiated thyroid cancer; citation_author=K Kulkarni, D Nostrand, F Atkins, M Aiken, K Burman, L Wartofsky; citation_volume=16; citation_publication_date=2006; citation_pages=1019-1023; citation_doi=10.1089/thy.2006.16.1019; citation_id=CR53 citation_journal_title=Endocr Relat Cancer; citation_title=Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma; citation_author=H Hanscheid, M Lassmann, M Luster, R Kloos, C Reiners; citation_volume=16; citation_publication_date=2009; citation_pages=1283-1289; citation_id=CR54 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patients; citation_author=FA Verburg, M Lassmann, U Mader, M Luster, C Reiners, H Hanscheid; citation_volume=38; citation_publication_date=2011; citation_pages=673-680; citation_doi=10.1007/s00259-010-1689-5; citation_id=CR55 citation_journal_title=N Engl J Med; citation_title=Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer; citation_author=HR Maxon, SR Thomas, VS Hertzberg, JG Kereiakes, IW Chen, MI Sperling, EL Saenger; citation_volume=309; citation_publication_date=1983; citation_pages=937-941; citation_doi=10.1056/NEJM198310203091601; citation_id=CR56 citation_journal_title=J Nucl Med; citation_title=Radioiodine-131 therapy for well-differentiated thyroid cancer–a quantitative radiation dosimetric approach: outcome and validation in 85 patients; citation_author=HR Maxon, EE Englaro, SR Thomas, VS Hertzberg, JD Hinnefeld, LS Chen, H Smith, D Cummings, MD Aden; citation_volume=33; citation_publication_date=1992; citation_pages=1132-1136; citation_id=CR57 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer; citation_author=GD Flux, M Haq, SJ Chittenden, S Buckley, C Hindorf, K Newbold, CL Harmer; citation_volume=37; citation_publication_date=2010; citation_pages=270-275; citation_doi=10.1007/s00259-009-1261-3; citation_id=CR58 citation_journal_title=J Nucl Med; citation_title=Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software; citation_author=G Sgouros, KS Kolbert, A Sheikh, KS Pentlow, EF Mun, A Barth, RJ Robbins, SM Larson; citation_volume=45; citation_publication_date=2004; citation_pages=1366-1372; citation_id=CR59 citation_journal_title=Endocr Relat Cancer; citation_title=Dosimetry and thyroid cancer: the individual dosage of radioiodine; citation_author=M Lassmann, C Reiners, M Luster; citation_volume=17; citation_publication_date=2010; citation_pages=R161-R172; citation_doi=10.1677/ERC-10-0071; citation_id=CR60 citation_journal_title=J Nucl Med; citation_title=MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry–standardization of nomenclature; citation_author=WE Bolch, KF Eckerman, G Sgouros, SR Thomas; citation_volume=50; citation_publication_date=2009; citation_pages=477-484; citation_doi=10.2967/jnumed.108.056036; citation_id=CR61 citation_journal_title=J Nucl Med; citation_title=Three-dimensional radiobiologic dosimetry: application of radiobiologic modelling to patient-specific 3-dimensional imaging-based internal dosimetry; citation_author=AR Prideaux, H Song, RF Hobbs, B He, EC Frey, PW Ladenson, RL Wahl, G Sgouros; citation_volume=48; citation_publication_date=2007; citation_pages=1008-1016; citation_doi=10.2967/jnumed.106.038000; citation_id=CR62 citation_journal_title=Clin Nucl Med; citation_title=Low iodine diet in I-131 ablation of thyroid remnants; citation_author=HR Maxon, SR Thomas, A Boehringer, J Drilling, MI Sperling, JC Sparks, IW Chen; citation_volume=8; citation_publication_date=1983; citation_pages=123-126; citation_doi=10.1097/00003072-198303000-00006; citation_id=CR63 citation_journal_title=Endocr Pract; citation_title=Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey; citation_author=AM Sawka, DP Goldstein, L Thabane, JD Brierley, RW Tsang, L Rotstein, S Kamalanathan, B Zhao, A Gafni, S Straus, S Ezzat; citation_volume=14; citation_publication_date=2008; citation_pages=175-184; citation_doi=10.4158/EP.14.2.175; citation_id=CR64 citation_journal_title=Thyroid; citation_title=Two weeks of a low-iodine diet are equivalent to 3 weeks for lowering urinary iodine and increasing thyroid radioactive iodine uptake; citation_author=EP Morsch, R Vanacor, TW Furlanetto, H Schmid; citation_volume=21; citation_publication_date=2011; citation_pages=61-67; citation_doi=10.1089/thy.2010.0232; citation_id=CR65 citation_journal_title=Thyroid; citation_title=Development and in vitro characterization of human recombinant thyrotropin; citation_author=BD Weintraub, MW Szkudlinski; citation_volume=9; citation_publication_date=1999; citation_pages=447-450; citation_doi=10.1089/thy.1999.9.447; citation_id=CR66 citation_journal_title=J Clin Endocrinol Metab; citation_title=A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer; citation_author=BR Haugen, F Pacini, C Reiners, M Schlumberger, PW Ladenson, SI Sherman, DS Cooper, KE Graham, LE Braverman, MC Skarulis, TF Davies, LJ DeGroot, EL Mazzaferri, GH Daniels, DS Ross, M Luster, MH Samuels, DV Becker, HR Maxon, RR Cavalieri, CA Spencer, K McEllin, BD Weintraub, EC Ridgway; citation_volume=84; citation_publication_date=1999; citation_pages=3877-3885; citation_doi=10.1210/jc.84.11.3877; citation_id=CR67 citation_journal_title=Eur J Endocrinol; citation_title=Short-term hypothyroidism after levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences; citation_author=LH Duntas, B Biondi; citation_volume=156; citation_publication_date=2007; citation_pages=13-19; citation_doi=10.1530/eje.1.02310; citation_id=CR68 citation_journal_title=Thyroid; citation_title=Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomics comparison to recombinant thyrotropin administration; citation_author=M Luster, R Felbinger, M Dietlein, C Reiners; citation_volume=15; citation_publication_date=2005; citation_pages=1147-1155; citation_doi=10.1089/thy.2005.15.1147; citation_id=CR69 citation_journal_title=Thyroid; citation_title=Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy; citation_author=KH Dow, BR Ferrell, C Anello; citation_volume=7; citation_publication_date=1997; citation_pages=613-619; citation_doi=10.1089/thy.1997.7.613; citation_id=CR70 citation_journal_title=J Clin Endocrinol Metab; citation_title=A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal; citation_author=PR Schroeder, BR Haugen, F Pacini, C Reiners, M Schlumberger, SI Sherman, DS Cooper, KG Schuff, LE Braverman, MC Skarulis, TF Davies, EL Mazzaferri, GH Daniels, DS Ross, M Luster, MH Samuels, BD Weintraub, EC Ridgway, PW Ladenson; citation_volume=91; citation_publication_date=2006; citation_pages=878-884; citation_doi=10.1210/jc.2005-2064; citation_id=CR71 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma; citation_author=M Luster, SI Sherman, MC Skarulis, JR Reynolds, M Lassmann, H Hanscheid, C Reiners; citation_volume=30; citation_publication_date=2003; citation_pages=1371-1377; citation_doi=10.1007/s00259-003-1230-1; citation_id=CR72 citation_journal_title=J Nucl Med; citation_title=Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radio toxicity; citation_author=PW Rosario, MA Borges, S Purisch; citation_volume=49; citation_publication_date=2008; citation_pages=1776-1782; citation_doi=10.2967/jnumed.108.050591; citation_id=CR73 citation_journal_title=J Clin Endocrinol Metab; citation_title=Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between recombinant human thyrotropin stimulation and prolonged levothyroxine withdrawal; citation_author=A Frigo, A Dardano, E Danese, MV Davi, P Moghetti, C Colato, G Francia, F Bernardi, C Traino, F Monzani, M Ferdeghini; citation_volume=94; citation_publication_date=2009; citation_pages=3472-3476; citation_doi=10.1210/jc.2008-2830; citation_id=CR74 citation_journal_title=Onco Targets Ther; citation_title=Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management; citation_author=A Gramza, KG Schuff; citation_volume=1; citation_publication_date=2009; citation_pages=87-101; citation_id=CR75 citation_journal_title=J Clin Endocrinol Metab; citation_title=Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal; citation_author=R Elisei, M Schlumberger, A Driedger, C Reiners, RT Kloos, SI Sherman, B Haugen, C Corone, E Molinaro, L Grasso, S Leboulleux, I Rachinsky, M Luster, M Lassmann, NL Busaidy, RL Wahl, F Pacini, SY Cho, J Magner, A Pinchera, PW Ladenson; citation_volume=94; citation_publication_date=2009; citation_pages=4171-4179; citation_doi=10.1210/jc.2009-0869; citation_id=CR76 citation_journal_title=J Nucl Med; citation_title=Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal; citation_author=RM Tuttle, M Brokhin, G Omry, AJ Martorella, SM Larson, RK Grewal, M Fleisher, RJ Robbins; citation_volume=49; citation_publication_date=2008; citation_pages=764-770; citation_doi=10.2967/jnumed.107.049072; citation_id=CR77 citation_journal_title=J Clin Endocrinol Metab; citation_title=Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma; citation_author=M Luster, M Lassmann, H Haenscheid, U Michalowski, C Incerti, C Reiners; citation_volume=85; citation_publication_date=2000; citation_pages=3640-3645; citation_doi=10.1210/jc.85.10.3640; citation_id=CR78 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy; citation_author=B Keizer, B Brans, A Hoekstra, PM Zelissen, HP Koppeschaar, CJ Lips, PP Rijk, RA Dierckx, JM Klerk; citation_volume=30; citation_publication_date=2003; citation_pages=367-373; citation_doi=10.1007/s00259-002-1076-y; citation_id=CR79 citation_journal_title=Thyroid; citation_title=Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine; citation_author=RJ Robbins, A Driedger, J Magner; citation_volume=16; citation_publication_date=2006; citation_pages=1121-1130; citation_doi=10.1089/thy.2006.16.1121; citation_id=CR80 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen; citation_author=I Borget, H Remy, J Chevalier, M Ricard, M Allyn, M Schlumberger, G Pouvourville; citation_volume=35; citation_publication_date=2008; citation_pages=1457-1463; citation_doi=10.1007/s00259-008-0754-9; citation_id=CR81 citation_journal_title=Eur J Endocrinol; citation_title=Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with thyrogen and thyroid hormone withdrawal; citation_author=I Borget, C Corone, M Nocaudie, M Allyn, S Iacobelli, M Schlumberger, G Pouvourville; citation_volume=156; citation_publication_date=2007; citation_pages=531-538; citation_doi=10.1530/EJE-06-0724; citation_id=CR82 citation_journal_title=Eur J Endocrinol; citation_title=Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective; citation_author=P Mernagh, S Campbell, M Dietlein, M Luster, E Mazzaferri, AR Weston; citation_volume=155; citation_publication_date=2006; citation_pages=405-414; citation_doi=10.1530/eje.1.02223; citation_id=CR83 citation_journal_title=Minerva Endocrinol; citation_title=Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular cell origin; citation_author=P Zanotti-Fregonara, ME Toubert, D Taieb, L Ravasi, D Rubello, E Hindie; citation_volume=33; citation_publication_date=2008; citation_pages=53-65; citation_id=CR84 citation_journal_title=Eur J Nucl Med Mol Imaging; citation_title=Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium; citation_author=D Barbaro, M Grosso, G Boni, D Volterrani, P Lapi, C Pasquini, P Orsini, A Turco, G Meucci, MC Marzola, P Berti, P Miccoli, G Mariani, D Rubello; citation_volume=37; citation_publication_date=2009; citation_pages=242-249; citation_doi=10.1007/s00259-009-1254-2; citation_id=CR85 citation_journal_title=J Clin Endocrinol Metab; citation_title=Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients; citation_author=HP Tala Jury, MG Castagna, C Fioravanti, C Cipri, E Brianzoni, F Pacini; citation_volume=95; citation_publication_date=2010; citation_pages=230-237; citation_doi=10.1210/jc.2009-1624; citation_id=CR86